Consolidated Index of Controlled Substances
O
Ohmefentanyl‡ 
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl and Section 3 Beta-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
PubChem: 62279; ChemSpider: 56080; Wikipedia: Ohmefentanyl
Olanzapine
CA: [not controlled] CDSA Schedule IV Section 18 Subsection 34 Olanzapine
PubChem: 4585; ChemSpider: 10442212; Wikipedia: Olanzapine
Opium
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UK: MDA Part I Class A Section 1(a) Opium
UN: Narcotics Part 1 Section 1 Opium, Part 2 Section 4 Opium and Section 7 Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
Opium extracts
US: CSA Schedule II Section b Subsection 1 Item x Opium extracts
PubChem: 135312062 135320771
Opium fluid
US: CSA Schedule II Section b Subsection 1 Item xi Opium fluid
PubChem: 160615 53477776
Opium poppy
CA: CDSA Schedule I Section 1 Opium poppy
US: CSA Schedule II Section b Subsection 3 Opium poppy
Drugs Forum: Poppy; Wikipedia: Opium poppy
Oripavine
UK: MDA Part III Class C Section 1(b) Oripavine
UN: Narcotics Part 1 Section 1 Oripavine
US: CSA Schedule II Section b Subsection 1 Item xii Oripavine
PubChem: 5462306; ChemSpider: 4575366; Drugs Forum: Oripavine; Wikipedia: Oripavine
Ovandrotone
UK: MDA Part III Class C Section 1(b) Ovandrotone
PubChem: 57225475
Oxabolone
CA: CDSA Schedule IV Section 23 Subsection 32 Oxabolone
UK: MDA Part III Class C Section 1(b) Oxabolone
PubChem: 107580; ChemSpider: 16736429
Oxandrolone
CA: CDSA Schedule IV Section 23 Subsection 33 Oxandrolone
UK: MDA Part III Class C Section 1(b) Oxandrolone
US: CSA Schedule III Section f Subsection 1 Item 55 Oxandrolone
PubChem: 5878; ChemSpider: 5667; Bluelight: Oxandrolone; Drugs Forum: Oxandrolone; Erowid: Steroids; Wikipedia: Oxandrolone
Oxazepam
CA: CDSA Schedule IV Section 18 Subsection 26 Oxazepam
UK: MDA Part III Class C Section 1(a) Oxazepam
UN: Psychotropics Schedule IV Oxazepam
US: CSA Schedule IV Section c Subsection 41 Oxazepam
PubChem: 4616; ChemSpider: 4455; Bluelight: Oxazepam; Drugs Forum: Oxazepam; Wikipedia: Oxazepam
Oxazolam
CA: CDSA Schedule IV Section 18 Subsection 27 Oxazolam
UK: MDA Part III Class C Section 1(a) Oxazolam
UN: Psychotropics Schedule IV Oxazolam
US: CSA Schedule IV Section c Subsection 42 Oxazolam
PubChem: 4617; ChemSpider: 4456; Wikipedia: Oxazolam
Oxpheneridine
CA: [not controlled] CDSA Schedule I Section 3 Subsection 24 Oxpheneridine
PubChem: 56863; ChemSpider: 51270; Wikipedia: Oxpheneridine
Oxycodone
CA: CDSA Schedule I Section 1 Subsection 28 Oxycodone
UK: MDA Part I Class A Section 1(a) Oxycodone
UN: Narcotics Part 1 Section 1 Oxycodone
US: CSA Schedule II Section b Subsection 1 Item xiii Oxycodone
PubChem: 5284603; ChemSpider: 4447649; Bluelight: Oxycodone; Drugs Forum: Oxycodone; Erowid: Oxycodone; Wikipedia: Oxycodone
Oxymesterone
CA: CDSA Schedule IV Section 23 Subsection 34 Oxymesterone
UK: MDA Part III Class C Section 1(b) Oxymesterone
US: CSA Schedule III Section f Subsection 1 Item 56 Oxymesterone
PubChem: 72061; ChemSpider: 65047; Erowid: Steroids; Wikipedia: Oxymesterone
Oxymetholone
CA: CDSA Schedule IV Section 23 Subsection 35 Oxymetholone
UK: MDA Part III Class C Section 1(b) Oxymetholone
US: CSA Schedule III Section f Subsection 1 Item 57 Oxymetholone
PubChem: 3032303; ChemSpider: 4444502; Bluelight: Oxymetholone; Erowid: Steroids; Wikipedia: Oxymetholone
Oxymorphone
CA: CDSA Schedule I Section 1 Subsection 29 Oxymorphone
UK: MDA Part I Class A Section 1(a) Oxymorphone
UN: Narcotics Part 1 Section 1 Oxymorphone
US: CSA Schedule II Section b Subsection 1 Item xiv Oxymorphone
PubChem: 5284604; ChemSpider: 4447650; Bluelight: Oxymorphone; Drugs Forum: Oxymorphone; Erowid: Oxymorphone; Wikipedia: Oxymorphone
11 March 2016 · Creative Commons BY-NC-SA ·